| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3317776 | Pancreatology | 2013 | 7 Pages |
Abstract
Our results implied that NAM might be a potential therapeutic agent for human pancreatic cancer treatment through downregulating SIRT1, K-Ras and P-Akt expression.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jun-gang Zhang, Gang Zhao, Qi Qin, Bo Wang, Lin Liu, Yang Liu, Shi-chang Deng, Kui Tian, Chun-you Wang,